Clinical Trials in Goyang, South Korea
36 recruiting
Showing 1–20 of 31 trials
Recruiting
Phase 3
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Non-small Cell Lung Cancer
Boehringer Ingelheim400 enrolled200 locationsNCT07195695
Recruiting
Phase 3
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Boehringer Ingelheim286 enrolled277 locationsNCT07220083
Recruiting
Phase 3
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy
Extensive-stage Small Cell Lung Cancer (ES-SCLC)Small Cell Lung Cancer ( SCLC )
Boehringer Ingelheim670 enrolled236 locationsNCT07472517
Recruiting
Phase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves Disease
Immunovant Sciences GmbH210 enrolled145 locationsNCT07018323
Recruiting
Phase 4
Study to Evaluate a New Cartilage Regeneration Platform for Knee Cartilage Repair
Cartilage Defects of the Knee
ROKIT Healthcare104 enrolled13 locationsNCT07639424
Recruiting
Phase 3
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Metastatic Clear Cell Renal Cell CarcinomaAdvanced Clear Cell Renal Cell Carcinoma
Arcus Biosciences, Inc.720 enrolled118 locationsNCT07011719
Recruiting
Phase 3
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Endometrial Cancer
BioNTech SE480 enrolled156 locationsNCT06340568
Recruiting
Phase 1Phase 2
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Gastric CancersColorectal, CancerPancreatic Cancer+1 more
Bold Therapeutics, Inc.220 enrolled24 locationsNCT04421820
Recruiting
Phase 3
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Breast Cancer
Celcuity Inc1,180 enrolled203 locationsNCT06757634
Recruiting
Phase 1
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Vividion Therapeutics, Inc.290 enrolled26 locationsNCT05954312
Recruiting
Phase 2
A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
TMB-HHistologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors
ImmuneOncia Therapeutics Inc.30 enrolled4 locationsNCT06365840
Recruiting
Phase 1Phase 2
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Regeneron Pharmaceuticals387 enrolled40 locationsNCT03761108
Recruiting
Streamlining Radioembolization for Small HCC
Hepatocellular Carcinoma (HCC)
Seoul National University Hospital146 enrolled4 locationsNCT06979219
Recruiting
Same-day Radioembolization for Large HCC
Hepatocellular Carcinoma (HCC)
Seoul National University Hospital138 enrolled4 locationsNCT06944483
Recruiting
Phase 3
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Lung Cancer, Non-squamous, Non-small Cell
Boehringer Ingelheim416 enrolled162 locationsNCT06151574
Recruiting
Phase 2
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Colorectal, CancerCancer CachexiaCRC (Colorectal Cancer)
NGM Biopharmaceuticals, Inc136 enrolled28 locationsNCT07033026
Recruiting
Phase 2Phase 3
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
Metastatic Urothelial Cancer
BicycleTx Limited956 enrolled170 locationsNCT06225596
Recruiting
Phase 2
Study of Novel Treatment Combinations in Patients With Lung Cancer
Lung CancerAdvanced or Metastatic Non-small Cell Lung CancerResectable Non-small Cell Lung Cancer
Gilead Sciences270 enrolled100 locationsNCT05633667
Recruiting
Phase 2
Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI
Contrast-Induced Acute Kidney Injury
Aptabio Therapeutics, Inc.280 enrolled14 locationsNCT05758896
Recruiting
Not Applicable
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Advanced Breast CancerEarly Breast CancerAdvanced Lung Cancer+5 more
Ulsan University Hospital414 enrolled5 locationsNCT07405931